Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector

2 Feb 2021

Abstract excerpt

The spike (S) protein is one of the three proteins forming the coronaviruses' viral envelope. The S protein of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has a spatial structure similar to the S proteins of other mammalian coronaviruses, except for a unique receptor-binding domain (RBD), which is a significant inducer of host immune response. Recombinant SARS-CoV-2 RBD is widely used as a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33529230
DOI: 10.1371/journal.pone.0242890

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vectorPMID 33529230Read ↗

High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the <i>EEF1A1</i> -based plasmid vectorSemantic proximity Read ↗

Recombinant SARS-CoV-2 spike proteins for sero-surveillance and epitope mappingSemantic proximity Read ↗

A broadly protective CHO cell expressed recombinant spike protein subunit vaccine (IMT-CVAX) against SARS-CoV-2Semantic proximity Read ↗

Designed SARS‐CoV‐2 receptor binding domain variants form stable monomersSemantic proximity Read ↗

Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cellsSemantic proximity Read ↗

Serum‐free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivitySemantic proximity Read ↗

Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic AnalysisSemantic proximity Read ↗

Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cellsSemantic proximity Read ↗

An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia pastoris as a Candidate Vaccine AntigenSemantic proximity Read ↗

Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell PoolSemantic proximity Read ↗

Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine DesignSemantic proximity Read ↗

Identification of Two Neutralizing Regions on the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Produced from the Mammalian Expression SystemSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.